Literature DB >> 27071857

Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Alessandro Pompoli1, Toshi A Furukawa, Hissei Imai, Aran Tajika, Orestis Efthimiou, Georgia Salanti.   

Abstract

BACKGROUND: Panic disorder is characterised by the presence of recurrent unexpected panic attacks, discrete periods of fear or anxiety that have a rapid onset and include symptoms such as racing heart, chest pain, sweating and shaking. Panic disorder is common in the general population, with a lifetime prevalence of 1% to 4%. A previous Cochrane meta-analysis suggested that psychological therapy (either alone or combined with pharmacotherapy) can be chosen as a first-line treatment for panic disorder with or without agoraphobia. However, it is not yet clear whether certain psychological therapies can be considered superior to others. In order to answer this question, in this review we performed a network meta-analysis (NMA), in which we compared eight different forms of psychological therapy and three forms of a control condition.
OBJECTIVES: To assess the comparative efficacy and acceptability of different psychological therapies and different control conditions for panic disorder, with or without agoraphobia, in adults. SEARCH
METHODS: We conducted the main searches in the CCDANCTR electronic databases (studies and references registers), all years to 16 March 2015. We conducted complementary searches in PubMed and trials registries. Supplementary searches included reference lists of included studies, citation indexes, personal communication to the authors of all included studies and grey literature searches in OpenSIGLE. We applied no restrictions on date, language or publication status. SELECTION CRITERIA: We included all relevant randomised controlled trials (RCTs) focusing on adults with a formal diagnosis of panic disorder with or without agoraphobia. We considered the following psychological therapies: psychoeducation (PE), supportive psychotherapy (SP), physiological therapies (PT), behaviour therapy (BT), cognitive therapy (CT), cognitive behaviour therapy (CBT), third-wave CBT (3W) and psychodynamic therapies (PD). We included both individual and group formats. Therapies had to be administered face-to-face. The comparator interventions considered for this review were: no treatment (NT), wait list (WL) and attention/psychological placebo (APP). For this review we considered four short-term (ST) outcomes (ST-remission, ST-response, ST-dropouts, ST-improvement on a continuous scale) and one long-term (LT) outcome (LT-remission/response). DATA COLLECTION AND ANALYSIS: As a first step, we conducted a systematic search of all relevant papers according to the inclusion criteria. For each outcome, we then constructed a treatment network in order to clarify the extent to which each type of therapy and each comparison had been investigated in the available literature. Then, for each available comparison, we conducted a random-effects meta-analysis. Subsequently, we performed a network meta-analysis in order to synthesise the available direct evidence with indirect evidence, and to obtain an overall effect size estimate for each possible pair of therapies in the network. Finally, we calculated a probabilistic ranking of the different psychological therapies and control conditions for each outcome. MAIN
RESULTS: We identified 1432 references; after screening, we included 60 studies in the final qualitative analyses. Among these, 54 (including 3021 patients) were also included in the quantitative analyses. With respect to the analyses for the first of our primary outcomes, (short-term remission), the most studied of the included psychological therapies was CBT (32 studies), followed by BT (12 studies), PT (10 studies), CT (three studies), SP (three studies) and PD (two studies).The quality of the evidence for the entire network was found to be low for all outcomes. The quality of the evidence for CBT vs NT, CBT vs SP and CBT vs PD was low to very low, depending on the outcome. The majority of the included studies were at unclear risk of bias with regard to the randomisation process. We found almost half of the included studies to be at high risk of attrition bias and detection bias. We also found selective outcome reporting bias to be present and we strongly suspected publication bias. Finally, we found almost half of the included studies to be at high risk of researcher allegiance bias.Overall the networks appeared to be well connected, but were generally underpowered to detect any important disagreement between direct and indirect evidence. The results showed the superiority of psychological therapies over the WL condition, although this finding was amplified by evident small study effects (SSE). The NMAs for ST-remission, ST-response and ST-improvement on a continuous scale showed well-replicated evidence in favour of CBT, as well as some sparse but relevant evidence in favour of PD and SP, over other therapies. In terms of ST-dropouts, PD and 3W showed better tolerability over other psychological therapies in the short term. In the long term, CBT and PD showed the highest level of remission/response, suggesting that the effects of these two treatments may be more stable with respect to other psychological therapies. However, all the mentioned differences among active treatments must be interpreted while taking into account that in most cases the effect sizes were small and/or results were imprecise. AUTHORS'
CONCLUSIONS: There is no high-quality, unequivocal evidence to support one psychological therapy over the others for the treatment of panic disorder with or without agoraphobia in adults. However, the results show that CBT - the most extensively studied among the included psychological therapies - was often superior to other therapies, although the effect size was small and the level of precision was often insufficient or clinically irrelevant. In the only two studies available that explored PD, this treatment showed promising results, although further research is needed in order to better explore the relative efficacy of PD with respect to CBT. Furthermore, PD appeared to be the best tolerated (in terms of ST-dropouts) among psychological treatments. Unexpectedly, we found some evidence in support of the possible viability of non-specific supportive psychotherapy for the treatment of panic disorder; however, the results concerning SP should be interpreted cautiously because of the sparsity of evidence regarding this treatment and, as in the case of PD, further research is needed to explore this issue. Behaviour therapy did not appear to be a valid alternative to CBT as a first-line treatment for patients with panic disorder with or without agoraphobia.

Entities:  

Mesh:

Year:  2016        PMID: 27071857      PMCID: PMC7104662          DOI: 10.1002/14651858.CD011004.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  162 in total

1.  A crossover study of focused cognitive therapy for panic disorder.

Authors:  A T Beck; L Sokol; D A Clark; R Berchick; F Wright
Journal:  Am J Psychiatry       Date:  1992-06       Impact factor: 18.112

2.  Breathing retraining, exposure and a combination of both, in the treatment of panic disorder with agoraphobia.

Authors:  C de Ruiter; H Ryken; B Garssen; F Kraaimaat
Journal:  Behav Res Ther       Date:  1989

3.  Treatment choice for agoraphobic women: exposure or cognitive-behaviour therapy?

Authors:  M Burke; L M Drummond; D W Johnston
Journal:  Br J Clin Psychol       Date:  1997-09

4.  Longitudinal study of the influence of life events and personality status on diagnostic change in three neurotic disorders.

Authors:  N Seivewright; P Tyrer; B Ferguson; S Murphy; T Johnson
Journal:  Depress Anxiety       Date:  2000       Impact factor: 6.505

Review 5.  Hyperventilation in panic disorder and asthma: empirical evidence and clinical strategies.

Authors:  Alicia E Meuret; Thomas Ritz
Journal:  Int J Psychophysiol       Date:  2010-05-25       Impact factor: 2.997

Review 6.  Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults.

Authors:  Hui Li; Jijun Wang; Chunbo Li; Zeping Xiao
Journal:  Cochrane Database Syst Rev       Date:  2014-09-17

7.  Two-year follow-up after a randomised controlled trial of self- and clinician-accompanied exposure for phobia/panic disorders.

Authors:  J M Park; D Mataix-Cols; I M Marks; T Ngamthipwatthana; M Marks; R Araya; T Al-Kubaisy
Journal:  Br J Psychiatry       Date:  2001-06       Impact factor: 9.319

8.  An experimental investigation of the role of safety-seeking behaviours in the maintenance of panic disorder with agoraphobia.

Authors:  P M Salkovskis; D M Clark; A Hackmann; A Wells; M G Gelder
Journal:  Behav Res Ther       Date:  1999-06

Review 9.  Psychological treatment of panic: work in progress on outcome, active ingredients, and follow-up.

Authors:  J Margraf; D H Barlow; D M Clark; M J Telch
Journal:  Behav Res Ther       Date:  1993-01

10.  Changes in automatic threat processing precede and predict clinical changes with exposure-based cognitive-behavior therapy for panic disorder.

Authors:  Andrea Reinecke; Lara Waldenmaier; Myra J Cooper; Catherine J Harmer
Journal:  Biol Psychiatry       Date:  2013-03-16       Impact factor: 13.382

View more
  20 in total

Review 1.  Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults.

Authors:  Hui Li; Jijun Wang; Chunbo Li; Zeping Xiao
Journal:  Cochrane Database Syst Rev       Date:  2014-09-17

2.  Panic Disorder in Primary Care.

Authors:  Jochen Gensichen; Thomas S Hiller; Jörg Breitbart; Christian Brettschneider; Tobias Teismann; Ulrike Schumacher; Karoline Lukaschek; Mercedes Schelle; Nico Schneider; Michael Sommer; Michel Wensing; Hans-Helmut König; Jürgen Margraf
Journal:  Dtsch Arztebl Int       Date:  2019-03-08       Impact factor: 5.594

3.  Targets and outcomes of psychotherapies for mental disorders: an overview.

Authors:  Pim Cuijpers
Journal:  World Psychiatry       Date:  2019-10       Impact factor: 49.548

Review 4.  Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials.

Authors:  Joseph K Carpenter; Leigh A Andrews; Sara M Witcraft; Mark B Powers; Jasper A J Smits; Stefan G Hofmann
Journal:  Depress Anxiety       Date:  2018-02-16       Impact factor: 6.505

5.  Patients Characteristics and Psychosocial Treatment in Psychodynamic and Cognitive Behavior Therapy.

Authors:  Beate Muschalla; Michael Linden; Matthias Rose
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

Review 6.  Antidepressants versus placebo for panic disorder in adults.

Authors:  Irene Bighelli; Mariasole Castellazzi; Andrea Cipriani; Francesca Girlanda; Giuseppe Guaiana; Markus Koesters; Giulia Turrini; Toshi A Furukawa; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

7.  The Cyclic Vomiting Syndrome Threshold: A Framework for Understanding Pathogenesis and Predicting Successful Treatments.

Authors:  David J Levinthal
Journal:  Clin Transl Gastroenterol       Date:  2016-10-27       Impact factor: 4.488

8.  Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders.

Authors:  Jan Prasko; Ales Grambal; Petra Kasalova; Dana Kamardova; Marie Ociskova; Michaela Holubova; Kristyna Vrbova; Zuzana Sigmundova; Klara Latalova; Milos Slepecky; Marta Zatkova
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-17       Impact factor: 2.570

Review 9.  Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Authors:  Alessandro Pompoli; Toshi A Furukawa; Hissei Imai; Aran Tajika; Orestis Efthimiou; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2016-04-13

Review 10.  Fatigue as the Chief Complaint–Epidemiology, Causes, Diagnosis, and Treatment.

Authors:  Peter Maisel; Erika Baum; Norbert Donner-Banzhoff
Journal:  Dtsch Arztebl Int       Date:  2021-08-23       Impact factor: 8.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.